| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 182.99M | 182.96M | 222.43M | 262.42M | 243.60M |
| Gross Profit | 60.26M | 53.33M | 73.73M | 80.67M | 85.41M |
| EBITDA | -134.00K | -33.57M | -4.92M | 41.42M | 19.55M |
| Net Income | -24.19M | -51.26M | -24.23M | 27.88M | 3.83M |
Balance Sheet | |||||
| Total Assets | 755.17M | 816.34M | 877.38M | 927.08M | 989.50M |
| Cash, Cash Equivalents and Short-Term Investments | 143.20M | 151.32M | 145.18M | 144.68M | 208.22M |
| Total Debt | 2.33M | 2.36M | 2.46M | 2.47M | 1.69M |
| Total Liabilities | 53.47M | 61.70M | 64.09M | 76.80M | 111.31M |
| Stockholders Equity | 701.70M | 754.65M | 813.28M | 850.28M | 878.19M |
Cash Flow | |||||
| Free Cash Flow | -10.18M | 6.79M | 4.49M | -44.75M | -44.62M |
| Operating Cash Flow | -2.10M | 15.37M | 18.06M | -23.89M | -7.71M |
| Investing Cash Flow | -9.05M | -11.32M | -9.02M | -44.02M | -35.94M |
| Financing Cash Flow | -955.00K | -1.62M | -1.20M | -6.14M | -7.12M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
79 Outperform | HK$25.78B | 5.92 | 29.89% | ― | 40.36% | 64.59% | |
75 Outperform | HK$69.36B | 5.48 | 16.64% | 0.82% | 13.01% | 72.27% | |
69 Neutral | HK$9.95B | 1.96 | 24.76% | 3.00% | 29.47% | 436.16% | |
63 Neutral | HK$64.43B | 9.04 | 5.99% | ― | 12.30% | 1.48% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
60 Neutral | HK$59.80B | 9.70 | 10.36% | 1.84% | 1.34% | -17.40% | |
48 Neutral | HK$120.00M | -1.63 | -3.32% | ― | 0.02% | 52.81% |